Expectations and Beliefs of Transgender People Regarding Hormonal Treatment
NCT ID: NCT05474768
Last Updated: 2022-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2022-02-02
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Demographic Characteristics and Psychosocial Health of Transgender People
NCT04554849
Fertility Desires and Reproductive Needs of Transgender People
NCT03836027
Cardiomodulatory Effects of Gender-Affirming Hormone Therapy
NCT07128771
Gender Dysphoria in Children and Adolescents : Parents' Perspectives
NCT04160364
Retrospective Study of the Cohort of Transgender Patients Who Began Medical Support Before the Age of 18
NCT07163832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* adult subject (age \> 18 years) presenting Gender dysphoria
* Severe, uncontrolled psychiatric or somatic illness
* Chronic alcoholism
* Substance abuse
* Refusal or linguistic, physical or psychological incapacity to participate in the study
* Ongoing pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
EVA FEIGERLOVA
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021PI221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.